Middle East & Africa Animal Parasiticides Market Overview
The Middle East & Africa animal parasiticides market was valued at USD 698.43 billion in 2025 and is projected to reach USD 1,132.10 million by 2033, growing at a CAGR of 6.41% from 2026 to 2033. The market is supported by sustained demand for preventive and therapeutic parasite control across companion and farm animals, increasing awareness of zoonotic parasite risks, and the continued development of convenient topical, oral, and combination parasiticide products.
Middle East & Africa represents a mature animal-health market with a broad veterinary infrastructure, established pharmaceutical manufacturers, and a large companion-animal population. Fleas, ticks, mites, and intestinal worms remain important parasite-control targets, while climate variability, cross-border animal movement, and travel can contribute to changing parasite exposure patterns. AnimalhealthMiddle East & Africa identifies parasite control as a cornerstone of veterinary care and notes that parasites can affect both animal and human health.
Key Market Trends & Insights
- South Africa dominated the Middle East & Africa animal parasiticides market with the largest revenue share of 24.81% in 2025, supported by supported by its well-established veterinary healthcare infrastructure, high demand for companion-animal healthcare, strong adoption of preventive parasite-control products, and the presence of leading animal health companies and veterinary pharmaceutical manufacturers.
- The ectoparasiticides segment dominated the Middle East & Africa animal parasiticides market with a 49.67% share in 2026, supported by continued demand for flea and tick control products across companion and farm animals.
- Saudi Arabia is expected to be the fastest-growing region at a CAGR of 7.30% from 2026 to 2033, fueled by a growing companion animal population, increasing awareness of preventive veterinary care, rising demand for flea and tick control products, and expanding access to veterinary healthcare and animal health products.
- The Organochlorines segment within drug class dominated with a 3.23% share in 2025, while the carbamates segment is projected to register the fastest growth at a CAGR of 6.33% from 2026 to 2033.
- Prescription products dominated the mode of purchase category with a 62.54% share in 2025, reflecting the important role of veterinary diagnosis, treatment recommendations, and prescription-based parasite control.
- Branded products accounted for the largest drug type share at 61.30% in 2025, while generic products are expected to grow faster at a CAGR of 6.22% through 2033.
- Topical products led the route of administration category with a 42.29% share in 2025, whereas oral products are expected to record the fastest CAGR of 6.24% from 2026 to 2033.
Market Size & Forecast
- Market Value (2025): USD 698.43 Million
- Expected Market Value (2033): USD 1,132.10 Million
- Forecast CAGR (2026–2033): 6.41%
- Leading Region in 2025: South Africa
- Fastest Growing Region: Saudi Arabia
Report Scope and Middle East & Africa Animal Parasiticides Market Segmentation
|
Attributes |
Animal Parasiticides Key Market Insights |
|
Segments Covered |
|
|
Countries Covered |
|
|
Key Market Players |
|
|
Market Opportunities |
|
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework |
Middle East & Africa Animal Parasiticides Market Trends
Trend: Growth in Demand for Novel Biological and Low-Chemical Residue Parasiticide Solutions
The increasing focus on sustainable animal healthcare practices is creating opportunities for the development of novel biological and low-chemical residue parasiticide solutions. Growing awareness regarding environmental impacts, chemical residues, and the need for safer parasite control approaches is encouraging manufacturers to explore alternative solutions that provide effective parasite management while reducing potential risks to animals, humans, and ecosystems. This shift is driving innovation toward advanced formulations with improved safety profiles and sustainable characteristics.
The rising preference for responsible livestock production and eco-conscious companion animal care is further supporting opportunities for companies to develop next-generation parasiticide products. Biological approaches, naturally derived active ingredients, and low-residue formulations can help address evolving regulatory expectations and consumer preferences for safer animal healthcare solutions. As the animal health industry moves toward more sustainable disease prevention strategies, the development of environmentally compatible parasiticides is expected to create new growth opportunities for market participants.
For instances,
- In October 2025, the U.S. Department of Agriculture (USDA) APHIS highlighted biological control approaches as environmentally sound pest management methods that can reduce dependence on conventional chemical pesticides. The agency emphasized the use of natural biological agents as targeted control solutions within integrated pest management programs.
Middle East & Africa Animal Parasiticides Market Dynamics
Key Market Driver: Increasing Burden of Vector-Borne Parasites Affecting Animal Health
The rising occurrence of vector-borne parasites, including ticks, fleas, mites, and other external parasites, is becoming a significant concern for companion animals and livestock populations. These parasites can negatively impact animal health by causing skin disorders, infections, irritation, reduced immunity, and transmission of various diseases. Increasing exposure of animals to parasite-prone environments, including farms, rural areas, and outdoor habitats, is contributing to greater demand for effective parasite control solutions.
The growing focus on maintaining animal welfare and preventing parasite-related health issues is encouraging the adoption of animal parasiticides across veterinary and agricultural applications. Livestock producers are increasingly prioritizing parasite management to minimize health complications and maintain animal productivity, while pet owners are becoming more proactive toward routine parasite prevention. This shift toward preventive animal healthcare practices is supporting the increased utilization of parasiticide products for controlling vector-borne parasite infestations.
For instance,
-
As reported by the World Organisation for Animal Health (WOAH) in May 2024, vector-borne diseases are emerging as a significant threat to animal health, with vectors such as ticks, mosquitoes, and flies contributing to the spread of diseases among animals. The organization highlighted that changing environmental conditions are influencing vector distribution and increasing the requirement for improved surveillance and control measures for animal health protection.
Key Restraint/Challenge: Development of Parasite Resistance Against Commonly Used Active Ingredients
The increasing development of parasite resistance against commonly used active ingredients is emerging as a significant restraint for the global animal parasiticides market. Repeated and improper use of certain antiparasitic compounds can reduce their effectiveness over time, allowing resistant parasite populations to survive and continue affecting animal health. Resistance among internal and external parasites, including worms, ticks, and other ectoparasites, creates challenges for veterinarians, farmers, and pet owners in maintaining effective parasite control programs.
The reduced response to existing parasiticide treatments is increasing the complexity of parasite management and encouraging the need for alternative control strategies, improved monitoring practices, and development of new active ingredients. Resistance issues can increase treatment costs, require frequent product rotation, and limit the effectiveness of established parasiticide solutions. As resistance continues to impact long-term parasite control efforts, it remains a key challenge that may restrict the broader adoption and effectiveness of conventional animal parasiticides.
For instance,
-
As reported by the U.S. Food and Drug Administration (FDA) in January 2026, concerns regarding antiparasitic resistance in livestock animals continue to require attention, with the agency emphasizing responsible use of approved antiparasitic products and veterinary oversight to maintain treatment effectiveness. The increasing recognition of resistance risks highlights challenges associated with maintaining long-term efficacy of existing parasiticide solutions.
Key Market Opportunity: Expansion of Online Veterinary Services and Digital Animal Healthcare Platforms
The increasing adoption of digital technologies in animal healthcare is creating new opportunities for improving access to veterinary services and parasite management solutions. Online veterinary consultations, digital health platforms, and remote monitoring tools are enabling pet owners and livestock producers to receive timely healthcare guidance, including recommendations for parasite prevention and treatment. These platforms are improving awareness regarding animal health practices and supporting early identification and management of parasite-related conditions.
The growing integration of technology into veterinary care is transforming traditional animal healthcare models by enhancing communication between veterinarians and animal owners. Digital platforms provide opportunities for personalized healthcare recommendations, medication guidance, and continuous monitoring, helping improve compliance with preventive parasite control programs. As digitalization continues to expand across the animal health sector, online veterinary services are expected to support wider adoption of animal parasiticides by improving accessibility and awareness.
For instances,
- As reported by Pet 24-7 Global Ltd in June 2026, the company launched its connected pet healthcare platform in India and Saudi Arabia, integrating digital health records, preventive care reminders, AI-based pet assistance, and veterinary support services. The platform enables pet owners to manage healthcare activities digitally and access veterinary guidance more conveniently.
Middle East & Africa Animal Parasiticides Market Scope
The Middle East & Africa animal parasiticides market is segmented on the basis of product, drug class, mode of purchase, drug type, route of administration, dosage form, disease type, animal type, end user, and distribution channel.
-
By Product
On the basis of product, the market is segmented into ectoparasiticides, endoparasiticides, and endectocides. In 2026, the ectoparasiticides segment is expected to dominate the market with a market share of 49.67%, supported by demand for flea and tick control across companion and farm animals.
The endectocides segment is projected to register the fastest growth at a CAGR of 6.78% from 2026 to 2033, reflecting demand for products providing broader internal and external parasite coverage.
-
By Drug Class
On the basis of drug class, the market is segmented into organochlorines, organophosphates, carbamates, benzimidazoles, imidazothiazoles, and others. In 2026, the others segment is expected to dominate with a market share of 3.23%.
The carbamates segment is expected to register the fastest growth in the Middle East & Africa animal parasiticides market, expanding at a CAGR of 7.25% from 2026 to 2033, driven by increasing demand for effective parasite-control treatments and growing emphasis on preventive animal healthcare.
-
By Mode of Purchase
On the basis of mode of purchase, the market is segmented into prescription and over the counter (OTC). In 2026, prescription products are expected to dominate with a market share of 62.68%, supported by veterinary diagnosis and professional treatment recommendations.
The prescription segment is projected to register the fastest CAGR of 6.63% from 2026 to 2033, mainly due to the increasing demand for prescription-based antiparasitic treatments, greater veterinary healthcare expenditure, and the growing prevalence of parasitic infections in animals.
-
By Drug Type
On the basis of drug type, the market is segmented into branded and generic products. In 2026, branded products are expected to dominate with a market share of 61.19%, supported by established veterinary brands and product recognition.
The generic segment is expected to witness the fastest CAGR of 6.70% from 2026 to 2033, supported by growing demand for cost-effective treatment options, increasing preference for affordable alternatives to branded products, and the wider availability of generic antiparasitic drugs.
-
By Route of Administration
On the basis of route of administration, the market is segmented into topical, oral, injectables, and others. In 2026, topical products are expected to dominate with a market share of 42.23%, supported by their established use in ectoparasite control and convenient application.
The oral segment is expected to witness the fastest CAGR of 6.81% from 2026 to 2033, supported by the convenience of oral administration, ease of dosing, improved treatment compliance, and increasing adoption of systemic parasite-control products.
-
By Dosage Form
On the basis of dosage form, the market is segmented into solution, tablets, sprays, and others. In 2026, solution is expected to dominate with a market share of 43.64%, supported by the widespread use of topical and liquid parasite-control formulations.
The tablets segment is projected to record the fastest CAGR of 6.63% from 2026 to 2033, supported by convenient dosing, ease of administration, improved treatment compliance, and growing demand for oral parasite-control products.
-
By Disease Type
On the basis of disease type, the market is segmented into fleas, ticks, round worms, hookworms, ear mites, and others. In 2026, fleas are expected to dominate with a market share of 27.92%.
The ticks segment is expected to witness the fastest CAGR of 6.83% from 2026 to 2033, supported by the growing importance of tick-borne disease prevention, rising awareness of tick-related health risks, and changing parasite exposure pattern.
-
By Animal Type
On the basis of animal type, the market is segmented into companion animal and farm animals. In 2026, companion animals are expected to dominate with a market share of 75.86%, supported by high demand for routine flea, tick, and worm prevention in pets.
The farm animals segment is expected to witness the fastest CAGR of 6.83% from 2026 to 2033, supported by the rising prevalence of parasitic infections, increasing livestock populations, growing emphasis on animal health and productivity, and greater adoption of preventive parasite-control treatments.
-
By End User
On the basis of end user, the market is segmented into veterinary clinics, animal farms, home care, veterinary hospitals, pet shops, and others. In 2026, veterinary clinics are expected to dominate with a market share of 33.00%, reflecting their role in diagnosis, prescription, and parasite-control recommendations.
The home care segment is expected to witness the fastest CAGR of 6.79% from 2026 to 2033, supported by increasing preference for convenient at-home preventive care, greater awareness of routine parasite prevention, and the growing availability of easy-to-administer animal health products.
-
By Distribution Channel
On the basis of distribution channel, the market is segmented into retail sales, direct tender, and other. In 2026, retail sales are expected to dominate with a market share of 67.19%, supported by broad access to companion-animal parasite-control products through retail and pet-care channels.
The direct tender segment is expected to witness the fastest CAGR of 6.73% from 2026 to 2033, supported by increasing institutional and farm-level procurement, rising demand for bulk purchasing, and the growing adoption of organized procurement channels for animal health products.
South Africa Animal Parasiticides Market Insight
South Africa dominated the Middle East & Africa animal parasiticides market with the largest revenue share of 24.81% in 2025, supported by supported by its well-established veterinary healthcare infrastructure, high demand for companion-animal healthcare, strong adoption of preventive parasite-control products, and the presence of leading animal health companies and veterinary pharmaceutical manufacturers.
South Africa Animal Parasiticides Market Insight
The South Africa animal parasiticides market is driven by the country's large livestock sector, increasing companion-animal ownership, and rising awareness of preventive veterinary healthcare. Market growth is further supported by the need to control ticks, fleas, mites, gastrointestinal worms, and other parasites affecting cattle, sheep, poultry, and pets, along with expanding access to veterinary medicines through clinics, agricultural suppliers, and retail distribution channels.
Saudi Arabia Animal Parasiticides Market Insight
The Saudi Arabia animal parasiticides market is supported by increasing investments in livestock health, growing pet ownership, and rising awareness of preventive animal healthcare. Market growth is further driven by the demand for effective control of fleas, ticks, mites, and gastrointestinal parasites, supported by expanding veterinary services, government initiatives to strengthen animal health, and improved availability of animal healthcare products.
Egypt Animal Parasiticides Market Insight
The Egypt animal parasiticides market is driven by a large livestock population, increasing focus on disease prevention, and growing awareness of veterinary healthcare among livestock producers and pet owners. Market growth is further supported by rising demand for parasite-control products targeting fleas, ticks, mites, and internal worms, along with expanding veterinary infrastructure and improved access to animal health products.
United Arab Emirates Animal Parasiticides Market Insight
The United Arab Emirates animal parasiticides market is supported by rising companion-animal ownership, increasing expenditure on pet healthcare, and growing awareness of preventive veterinary care. Market growth is further encouraged by the demand for effective parasite-control products, including flea, tick, mite, and worm treatments, alongside well-developed veterinary services, specialty pet stores, and online distribution channels.
Middle East & Africa Animal Parasiticides Market Share
The animal parasiticides industry is primarily led by well-established companies, including:
- Zoetis Inc. (U.S.)
- Boehringer Ingelheim International GmbH (Germany)
- Bimeda, Inc. (Ireland)
- Biogénesis Bagó (Argentina)
- Ceva Santé Animale (France)
- Dechra Pharmaceuticals (U.K.)
- Elanco Animal Health Incorporated (U.S.)
- Merck & Co., Inc. (U.S.)
- Vetoquinol (France)
- Virbac (France)
- Norbrook (U.K.)
- FARMABASE (Spain)
- Ourofino Saúde Animal (Brazil)
- Phibro Animal Health Corporation (U.S.)
- PetIQ, LLC (U.S.)
- Chanelle Pharma (Ireland)
- Inmed Animal Health (U.S.)
- Viyash Scientific (India)
- Kyoritsu Seiyaku Corporation (Japan)
- KRKA, d. d., Novo mesto (Slovenia)
- Huvepharma (Bulgaria)
- Bioveta, a.s. (Czech Republic)
- Pecus Healthcare Pvt. Ltd. (India)
- PATCO Healthcare Pvt. Ltd. (India)
- Agrovet Market S.A. (Peru)
- Prodivet Pharmaceuticals S.A. (Belgium)
Latest Developments in Middle East & Africa Animal Parasiticides Market
- In September 2025, Zoetis Inc. announced that Dectomax-CA1 Injectable is the first and only parasite control product to receive conditional approval from the U.S. Food and Drug Administration for the prevention and treatment of infestations caused by the larvae of Cochliomyia hominivorax (myiasis), and prevention of reinfestation for 21 days. This conditional approval applies to beef cattle, female dairy cattle less than 20 months of age, pregnant beef cows, newborn calves and bulls.
- In February 2026, Boehringer Ingelheim, a global leader in animal health, announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the use of IVOMEC (ivermectin) 1% Injection for the prevention of infestations caused by New World screwworm (NWS) in cattle. Under the EUA, IVOMEC (ivermectin) 1% Injection is authorized for the prevention of infestations caused by NWS (Cochliomyia hominivorax) larvae (myiasis) when administered within 24 hours of birth, at the time of castration, or at the appearance of a wound in cattle, except for female dairy cattle producing milk for human consumption and calves that will be processed for veal.
- In June 2026, Ceva Animal Health announces the acquisition of Aquilón CyL S.L., a Spanish biotechnology company specialised in research, diagnostics, and the development of innovative biological solutions for swine diseases. This acquisition enhances Ceva’s swine intestinal health portfolio. It includes the first and only European commercial vaccine targeting Brachyspira hyodysenteriae, the bacterium responsible for swine dysentery, a major enteric disease causing severe economic losses globally.
- In May 2026, Ceva Animal Health (Ceva) and Mitsui & Co., Ltd. (Mitsui) announced the creation of Ceva Bussan Animal Health, a new joint venture that brings together Bussan Animal Health (BAH) and Ceva Japan. As part of the transaction, Mitsui has transferred 60% of its shareholding in BAH to Ceva. Ceva Bussan Animal Health will be operated by Ceva as a controlling shareholder and benefit from Mitsui’s ongoing support as a leading global trading and investment company headquartered in Japan.
- In February 2026, Ceva Animal Health is implementing strategic organisational changes across Asia Pacific (APAC) and China to accelerate growth and drive operational excellence. As part of this strategic realignment, Ceva has relocated its Asia-Pacific regional headquarters to Shanghai, positioning the company to serve the dynamic markets in the region more effectively.
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 DBMR MARKET POSITION GRID
2.7 VENDOR SHARE ANALYSIS
2.8 MULTIVARIATE MODELING
2.9 PRODUCT TYPE TIMELINE CURVE
2.1 MARKET APPLICATION COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES ANALYSIS
4.1.1 THREAT OF NEW ENTRANTS
4.1.2 BARGAINING POWER OF SUPPLIERS
4.1.3 BARGAINING POWER OF BUYERS
4.1.4 THREAT OF SUBSTITUTE PRODUCTS
4.1.5 INDUSTRY RIVALRY
4.2 PESTEL ANALYSIS
4.2.1 INTRODUCTION
4.2.2 POLITICAL FACTORS
4.2.2.1 ANIMAL DISEASE CONTROL POLICIES
4.2.2.2 GOVERNMENT LIVESTOCK HEALTH PROGRAMS
4.2.2.3 ZOONOTIC DISEASE PREVENTION INITIATIVES
4.2.3 ECONOMIC FACTORS
4.2.4 RISING VETERINARY HEALTHCARE COSTS
4.2.4.1 LIVESTOCK PRODUCTIVITY INVESTMENTS
4.2.4.2 DEMAND FOR AFFORDABLE TREATMENTS
4.2.4.3 EXPANSION OF ANIMAL HEALTHCARE SPENDING
4.2.4.4 GENERIC PARASITICIDE ADOPTION
4.2.5 SOCIAL FACTORS
4.2.5.1 GROWING ANIMAL HEALTH AWARENESS
4.2.5.2 PREVENTIVE PARASITE MANAGEMENT PRACTICES
4.2.5.3 RISING PET OWNERSHIP TRENDS
4.2.5.4 ANIMAL WELFARE CONCERNS
4.2.5.5 DEMAND FOR BETTER VETERINARY CARE
4.2.6 TECHNOLOGICAL FACTORS
4.2.6.1 ADVANCED PARASITICIDE FORMULATIONS
4.2.6.2 NOVEL DRUG DELIVERY SYSTEMS
4.2.6.3 DIGITAL VETERINARY PLATFORMS
4.2.6.4 IMPROVED PARASITE DIAGNOSTICS
4.2.6.5 RESEARCH ON NEW MOLECULES
4.2.7 ENVIRONMENTAL FACTORS
4.2.7.1 PARASITICIDE RESIDUE CONCERNS
4.2.7.2 VETERINARY WASTE MANAGEMENT
4.2.7.3 SUSTAINABLE MANUFACTURING PRACTICES
4.2.7.4 ECO-FRIENDLY PACKAGING ADOPTION
4.2.7.5 RESISTANCE MANAGEMENT INITIATIVES
4.2.8 LEGAL FACTORS
4.2.8.1 VETERINARY DRUG APPROVAL STANDARDS
4.2.8.2 SAFETY AND EFFICACY REGULATIONS
4.2.8.3 RESIDUE LIMIT COMPLIANCE
4.2.8.4 ANIMAL MEDICINE GUIDELINES
4.2.8.5 MIDDLE EAST AND AFRICA REGULATORY HARMONIZATION
4.2.9 CONCLUSION
4.3 PATENT ANALYSIS
4.3.1 PATENT NUMBER AND EXPIRY
4.3.2 COUNTRY-LEVEL APPROVAL
4.3.3 LIST OF PRODUCTS REACHING EXPIRY IN NEXT 3 YEARS
4.3.4 PRODUCTS PATENTED IN SPECIFIC COUNTRIES
4.3.5 CONCLUSION
4.4 INDUSTRY INSIGHTS
4.5 PIPELINE ANALYSIS
4.5.1 CLINICAL TRIALS AND PHASE ANALYSIS
4.5.2 PRODUCT PIPELINE FOR ANIMAL PARASITICIDES
4.5.3 TARGET ANIMAL SAFETY STUDIES (TASS)
4.5.4 TARGET ANIMAL EFFECTIVENESS STUDIES (TAES)
4.6 R & D ANALYSIS
4.7 EPIDEMIOLOGY
4.7.1 INTRODUCTION
4.7.2 INCIDENCE OF INFESTATION BY REGION
4.7.3 TREATMENT ADOPTION RATE
4.7.4 PARASITE-RELATED MORTALITY RATE
4.7.5 COMPLIANCE AND THERAPY SWITCH MODEL
4.7.6 TREATMENT SUCCESS RATES
4.7.7 CONCLUSION
4.8 MARKETED PRODUCT ANALYSIS
4.8.1 INTRODUCTION
4.8.2 PRODUCT
4.8.2.1 BRAND NAME
4.8.2.2 GENERIC NAME
4.8.3 THERAPEUTIC INDICATION
4.8.4 PHARMACOLOGICAL CLASSIFICATION
4.8.5 PRIMARY INDICATION
4.8.6 MARKET STATUS
4.8.7 MEDICATION TYPE
4.8.8 PRODUCT DOSAGE FORM
4.8.9 DOSAGE AVAILABILITY
4.8.10 PACKAGING TYPE
4.8.11 ROUTE OF ADMINISTRATION
4.8.12 DOSING FREQUENCY
4.8.13 PRODUCT INSIGHT
4.8.14 OVERVIEW OF PRODUCT DEVELOPMENT (REGULATORY MILESTONES, SAFETY, EFFICACY, MARKET EXCLUSIVITY DATA)
4.8.14.1 FORECAST MARKET OUTLOOK
4.8.14.2 CROSS COMPETITION
4.8.14.3 PRODUCT PORTFOLIO
4.8.14.4 URRENT DEVELOPMENT SCENARIO
4.8.15 CONCLUSION
4.9 MARKET ACCESS
4.9.1 INTRODUCTION
4.9.2 10-YEAR MARKET FORECAST
4.9.3 CLINICAL TRIAL RECENT UPDATES
4.9.4 ANNUAL NEW APPROVED PRODUCTS
4.9.5 MAJOR MANUFACTURERS AND PARTNERSHIPS
4.9.6 MAJOR PRODUCT UPTAKE
4.9.7 CURRENT TREATMENT PRACTICES
4.9.8 IMPACT OF UPCOMING THERAPY TRENDS
4.9.9 CONCLUSION
5 HEALTHCARE TARIFFS IMPACT ANALYSIS
5.1 OVERVIEW
5.2 TARIFF STRUCTURES
5.2.1 MIDDLE EAST AND AFRICA VS. REGIONAL TARIFF STRUCTURES
5.2.1.1 NORTH AMERICA
5.2.1.2 EUROPE
5.2.1.3 ASIA-PACIFIC
5.2.1.4 LATIN AMERICA
5.2.1.5 MIDDLE EAST AND AFRICA
5.2.2 UNITED STATES: USDA AND FDA TARIFF POLICIES, CMS PRICING MODELS
5.2.3 EUROPEAN UNION: CROSS-BORDER TARIFF REGULATIONS, REIMBURSEMENT POLICIES
5.2.4 ASIA-PACIFIC: GOVERNMENT-IMPOSED TARIFFS ON IMPORTED VETERINARY PRODUCTS
5.2.5 EMERGING MARKETS: CHALLENGES IN TARIFF IMPLEMENTATION
5.3 PHARMACEUTICAL TARIFFS AND TRADE BARRIERS
5.3.1 IMPORT DUTIES ON VETERINARY DRUGS VS. GENERICS
5.3.2 IMPACT ON PRODUCT AFFORDABILITY AND ACCESS
5.3.3 KEY TRADE AGREEMENTS AFFECTING TARIFFS
5.4 IMPACT OF HEALTHCARE TARIFFS ON PROVIDERS AND ANIMAL OWNERS
5.4.1 COST BURDEN ON FARMS, HOSPITALS, AND VETERINARY CLINICS
5.4.2 EFFECT ON PET OWNER AFFORDABILITY AND INSURANCE COVERAGE
5.4.3 TARIFFS AND THEIR ROLE IN VETERINARY TOURISM
5.5 TRADE AGREEMENTS AND HEALTHCARE TARIFFS
5.5.1 WTO REGULATIONS ON HEALTHCARE TARIFFS
5.5.2 IMPACT OF TRADE WARS ON SUPPLY CHAIN
5.5.3 WTO ROLE OF FREE TRADE AGREEMENTS IN REDUCING TARIFFS
5.6 IMPACT OF TARIFFS ON COSTS AND ACCESSIBILITY
5.7 IMPORTANCE OF TARIFFS IN THE SECTOR
6 REGULATORY FRAMEWORK
6.1 INTRODUCTION
6.2 REGULATORY APPROVAL PROCESS
6.3 GEOGRAPHIES’ EASE OF REGULATORY APPROVAL
6.4 REGULATORY APPROVAL PATHWAYS
6.5 LICENSING AND REGISTRATION
6.6 POST-MARKETING SURVEILLANCE
6.7 GOOD MANUFACTURING PRACTICES (GMPS) GUIDELINES
6.8 CONCLUSION
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING BURDEN OF VECTOR-BORNE PARASITES AFFECTING ANIMAL HEALTH.
7.1.2 RISING PET HUMANIZATION AND GROWING EXPENDITURE ON COMPANION ANIMAL WELLNESS.
7.1.3 INCREASING IMPORTANCE OF LIVESTOCK DISEASE MANAGEMENT FOR FOOD SUPPLY CHAIN STABILITY
7.1.4 INCREASING VETERINARY RECOMMENDATIONS FOR PREVENTIVE PARASITE CONTROL PRACTICES
7.2 RESTRAINTS
7.2.1 DEVELOPMENT OF PARASITE RESISTANCE AGAINST COMMONLY USED ACTIVE INGREDIENTS.
7.2.2 STRICT REGULATORY APPROVAL REQUIREMENTS FOR VETERINARY PHARMACEUTICAL PRODUCTS
7.3 OPPORTUNITIES
7.3.1 GROWTH IN DEMAND FOR NOVEL BIOLOGICAL AND LOW-CHEMICAL RESIDUE PARASITICIDE SOLUTIONS
7.3.2 EXPANSION OF ONLINE VETERINARY SERVICES AND DIGITAL ANIMAL HEALTHCARE PLATFORMS
7.3.3 DEVELOPMENT OF CUSTOMIZED PARASITE CONTROL SOLUTIONS BASED ON ANIMAL TYPE AND GEOGRAPHIC RISK
7.4 CHALLENGES
7.4.1 LIMITED VETERINARY INFRASTRUCTURE IN RURAL AND REMOTE FARMING COMMUNITIES
7.4.2 ENVIRONMENTAL IMPACT CONCERNS RELATED TO PARASITICIDE RESIDUES
8 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
8.2.1 ECTOPARASITICIDES
8.2.2 ENDOPARASITICIDES
8.2.3 ENDECTOCIDES
8.3 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
8.3.1 ECTOPARASITICIDES
8.3.2 ENDOPARASITICIDES
8.3.3 ENDECTOCIDES
8.4 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNIT)
8.4.1 ECTOPARASITICIDES
8.4.2 ENDOPARASITICIDES
8.4.3 ENDECTOCIDES
8.5 MIDDLE EAST AND AFRICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
8.5.1 BY TYPE
8.5.2 BY DOSAGE FORM
8.5.3 BY ROUTE OF ADMINISTRATION
8.6 MIDDLE EAST AND AFRICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.6.1 ORGANOPHOSPHATES
8.6.2 CARBAMATES
8.6.3 ORGANOCHLORINES
8.6.4 OTHERS
8.7 MIDDLE EAST AND AFRICA ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.7.1 LINDANE
8.7.2 DIELDRIN
8.7.3 OTHERS
8.8 MIDDLE EAST AND AFRICA CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.8.1 CARBARYL
8.8.2 METHOMYL
8.8.3 OTHERS
8.9 MIDDLE EAST AND AFRICA ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.9.1 CHLORPYRIFOS
8.9.2 AZAMETHIPHOS
8.9.3 CHLORFENVINPHOS
8.9.4 OTHERS
8.1 MIDDLE EAST AND AFRICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
8.10.1 SOLUTION
8.10.2 TABLETS
8.10.3 SPRAYS
8.10.4 OTHERS
8.11 MIDDLE EAST AND AFRICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
8.11.1 TOPICAL
8.11.2 ORAL
8.11.3 OTHERS
8.12 MIDDLE EAST AND AFRICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
8.12.1 NORTH AMERICA
8.12.2 EUROPE
8.12.3 ASIA-PACIFIC
8.12.4 SOUTH AMERICA
8.12.5 MIDDLE EAST & AFRICA
8.13 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
8.13.1 BY TYPE
8.13.2 BY DOSAGE FORM
8.13.3 BY ROUTE OF ADMINISTRATION
8.14 MIDDLE EAST AND AFRICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.14.1 BENZIMIDAZOLES
8.14.2 IMIDAZOTHIAZOLES
8.14.3 OTHERS
8.15 MIDDLE EAST AND AFRICA BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.15.1 ALBENDAZOLE
8.15.2 FENBENDAZOLE
8.15.3 FEBANTEL
8.15.4 OTHERS
8.16 MIDDLE EAST AND AFRICA IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.16.1 LEVAMISOLE
8.16.2 TETRAMISOLE
8.16.3 OTHERS
8.17 MIDDLE EAST AND AFRICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
8.17.1 SOLUTION
8.17.2 TABLETS
8.17.3 SPRAYS
8.17.4 OTHERS
8.18 MIDDLE EAST AND AFRICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
8.18.1 ORAL
8.18.2 INJECTABLES
8.18.3 TOPICAL
8.18.4 OTHERS
8.19 MIDDLE EAST AND AFRICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
8.19.1 NORTH AMERICA
8.19.2 EUROPE
8.19.3 ASIA-PACIFIC
8.19.4 SOUTH AMERICA
8.19.5 MIDDLE EAST & AFRICA
8.2 MIDDLE EAST AND AFRICA ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.20.1 ABAMECTIN
8.20.2 DORAMECTIN
8.20.3 OTHERS
8.21 MIDDLE EAST AND AFRICA ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
8.21.1 NORTH AMERICA
8.21.2 EUROPE
8.21.3 ASIA-PACIFIC
8.21.4 SOUTH AMERICA
8.21.5 MIDDLE EAST & AFRICA
9 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY DRUG CLASS
9.1 OVERVIEW
9.2 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
9.2.1 ORGANOCHLORINES
9.2.2 ORGANOPHOSPHATES
9.2.3 CARBAMATES
9.2.4 BENZIMIDAZOLES
9.2.5 IMIDAZOTHIAZOLES
9.2.6 OTHERS
9.3 MIDDLE EAST AND AFRICA ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.3.1 NORTH AMERICA
9.3.2 EUROPE
9.3.3 ASIA-PACIFIC
9.3.4 SOUTH AMERICA
9.3.5 MIDDLE EAST & AFRICA
9.4 MIDDLE EAST AND AFRICA ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.4.1 NORTH AMERICA
9.4.2 EUROPE
9.4.3 ASIA-PACIFIC
9.4.4 SOUTH AMERICA
9.4.5 MIDDLE EAST & AFRICA
9.5 MIDDLE EAST AND AFRICA CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.5.1 NORTH AMERICA
9.5.2 EUROPE
9.5.3 ASIA-PACIFIC
9.5.4 SOUTH AMERICA
9.5.5 MIDDLE EAST & AFRICA
9.6 MIDDLE EAST AND AFRICA BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.6.1 NORTH AMERICA
9.6.2 EUROPE
9.6.3 ASIA-PACIFIC
9.6.4 SOUTH AMERICA
9.6.5 MIDDLE EAST & AFRICA
9.7 MIDDLE EAST AND AFRICA IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.7.1 NORTH AMERICA
9.7.2 EUROPE
9.7.3 ASIA-PACIFIC
9.7.4 SOUTH AMERICA
9.7.5 MIDDLE EAST & AFRICA
9.8 MIDDLE EAST AND AFRICA OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.8.1 NORTH AMERICA
9.8.2 EUROPE
9.8.3 ASIA-PACIFIC
9.8.4 SOUTH AMERICA
9.8.5 MIDDLE EAST & AFRICA
10 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET , BY MODE OF PURCHASE
10.1 OVERVIEW
10.2 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
10.2.1 PRESCRIPTION
10.2.2 OVER THE COUNTER (OTC)
10.3 MIDDLE EAST AND AFRICA PRESCRIPTION IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.3.1 NORTH AMERICA
10.3.2 EUROPE
10.3.3 ASIA-PACIFIC
10.3.4 SOUTH AMERICA
10.3.5 MIDDLE EAST & AFRICA
10.4 MIDDLE EAST AND AFRICA OVER THE COUNTER (OTC) IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.4.1 NORTH AMERICA
10.4.2 EUROPE
10.4.3 ASIA-PACIFIC
10.4.4 SOUTH AMERICA
10.4.5 MIDDLE EAST & AFRICA
11 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET , BY DRUG TYPE
11.1 OVERVIEW
11.2 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
11.2.1 BRANDED
11.2.2 GENERIC
11.3 MIDDLE EAST AND AFRICA BRANDED IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
11.3.1 NORTH AMERICA
11.3.2 EUROPE
11.3.3 ASIA-PACIFIC
11.3.4 SOUTH AMERICA
11.3.5 MIDDLE EAST & AFRICA
11.4 MIDDLE EAST AND AFRICA GENERIC IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
11.4.1 NORTH AMERICA
11.4.2 EUROPE
11.4.3 ASIA-PACIFIC
11.4.4 SOUTH AMERICA
11.4.5 MIDDLE EAST & AFRICA
12 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION
12.1 OVERVIEW
12.2 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
12.2.1 TOPICAL
12.2.2 ORAL
12.2.3 INJECTABLES
12.2.4 OTHERS
12.3 MIDDLE EAST AND AFRICA TOPICAL IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.3.1 NORTH AMERICA
12.3.2 EUROPE
12.3.3 ASIA-PACIFIC
12.3.4 SOUTH AMERICA
12.3.5 MIDDLE EAST & AFRICA
12.4 MIDDLE EAST AND AFRICA ORAL IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.4.1 NORTH AMERICA
12.4.2 EUROPE
12.4.3 ASIA-PACIFIC
12.4.4 SOUTH AMERICA
12.4.5 MIDDLE EAST & AFRICA
12.5 MIDDLE EAST AND AFRICA INJECTABLES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.5.1 NORTH AMERICA
12.5.2 EUROPE
12.5.3 ASIA-PACIFIC
12.5.4 SOUTH AMERICA
12.5.5 MIDDLE EAST & AFRICA
12.6 MIDDLE EAST AND AFRICA OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.6.1 NORTH AMERICA
12.6.2 EUROPE
12.6.3 ASIA-PACIFIC
12.6.4 SOUTH AMERICA
12.6.5 MIDDLE EAST & AFRICA
13 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET , BY DOSAGE FORM
13.1 OVERVIEW
13.2 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
13.2.1 SOLUTION
13.2.2 TABLETS
13.2.3 SPRAYS
13.2.4 OTHERS
13.3 MIDDLE EAST AND AFRICA SOLUTION IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.3.1 NORTH AMERICA
13.3.2 EUROPE
13.3.3 ASIA-PACIFIC
13.3.4 SOUTH AMERICA
13.3.5 MIDDLE EAST & AFRICA
13.4 MIDDLE EAST AND AFRICA TABLETS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.4.1 NORTH AMERICA
13.4.2 EUROPE
13.4.3 ASIA-PACIFIC
13.4.4 SOUTH AMERICA
13.4.5 MIDDLE EAST & AFRICA
13.5 MIDDLE EAST AND AFRICA SPRAYS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.5.1 NORTH AMERICA
13.5.2 EUROPE
13.5.3 ASIA-PACIFIC
13.5.4 SOUTH AMERICA
13.5.5 MIDDLE EAST & AFRICA
13.6 MIDDLE EAST AND AFRICA OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.6.1 NORTH AMERICA
13.6.2 EUROPE
13.6.3 ASIA-PACIFIC
13.6.4 SOUTH AMERICA
13.6.5 MIDDLE EAST & AFRICA
14 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET , BY DISEASE TYPE
14.1 OVERVIEW
14.2 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE, 2018-2033 (USD THOUSAND)
14.2.1 FLEAS
14.2.2 TICKS
14.2.3 ROUND WORMS
14.2.4 HOOKWORMS
14.2.5 EAR MITES
14.2.6 OTHERS
14.3 MIDDLE EAST AND AFRICA FLEAS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.3.1 NORTH AMERICA
14.3.2 EUROPE
14.3.3 ASIA-PACIFIC
14.3.4 SOUTH AMERICA
14.3.5 MIDDLE EAST & AFRICA
14.4 MIDDLE EAST AND AFRICA TICKS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.4.1 NORTH AMERICA
14.4.2 EUROPE
14.4.3 ASIA-PACIFIC
14.4.4 SOUTH AMERICA
14.4.5 MIDDLE EAST & AFRICA
14.5 MIDDLE EAST AND AFRICA ROUND WORMS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.5.1 NORTH AMERICA
14.5.2 EUROPE
14.5.3 ASIA-PACIFIC
14.5.4 SOUTH AMERICA
14.5.5 MIDDLE EAST & AFRICA
14.6 MIDDLE EAST AND AFRICA HOOKWORMS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.6.1 NORTH AMERICA
14.6.2 EUROPE
14.6.3 ASIA-PACIFIC
14.6.4 SOUTH AMERICA
14.6.5 MIDDLE EAST & AFRICA
14.7 MIDDLE EAST AND AFRICA EAR MITES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.7.1 NORTH AMERICA
14.7.2 EUROPE
14.7.3 ASIA-PACIFIC
14.7.4 SOUTH AMERICA
14.7.5 MIDDLE EAST & AFRICA
14.8 MIDDLE EAST AND AFRICA OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.8.1 NORTH AMERICA
14.8.2 EUROPE
14.8.3 ASIA-PACIFIC
14.8.4 SOUTH AMERICA
14.8.5 MIDDLE EAST & AFRICA
15 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET , BY ANIMAL TYPE
15.1 OVERVIEW
15.2 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
15.2.1 COMPANION ANIMAL
15.2.2 FARM ANIMALS
15.3 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
15.3.1 DOGS
15.3.2 CATS
15.3.3 HORSES
15.3.4 OTHER COMPANION ANIMALS
15.4 MIDDLE EAST AND AFRICA COMPANION ANIMAL IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
15.4.1 NORTH AMERICA
15.4.2 EUROPE
15.4.3 ASIA-PACIFIC
15.4.4 SOUTH AMERICA
15.4.5 MIDDLE EAST & AFRICA
15.5 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
15.5.1 CATTLE
15.5.2 SWINE
15.5.3 SHEEP AND GOATS
15.5.4 POULTRY
15.5.5 OTHER FARM ANIMALS
15.6 MIDDLE EAST AND AFRICA FARM ANIMALS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
15.6.1 NORTH AMERICA
15.6.2 EUROPE
15.6.3 ASIA-PACIFIC
15.6.4 SOUTH AMERICA
15.6.5 MIDDLE EAST & AFRICA
16 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET , BY END USER
16.1 OVERVIEW
16.2 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
16.2.1 VETERINARY CLINICS
16.2.2 ANIMAL FARMS
16.2.3 HOME CARE
16.2.4 VETERINARY HOSPITALS
16.2.5 PET SHOPS
16.2.6 OTHERS
16.3 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
16.3.1 VETERINARY CLINICS
16.3.2 ANIMAL FARMS
16.3.3 HOME CARE
16.3.4 VETERINARY HOSPITALS
16.3.5 PET SHOPS
16.3.6 OTHERS
16.4 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNIT)
16.4.1 VETERINARY CLINICS
16.4.2 ANIMAL FARMS
16.4.3 HOME CARE
16.4.4 VETERINARY HOSPITALS
16.4.5 PET SHOPS
16.4.6 OTHERS
16.5 MIDDLE EAST AND AFRICA VETERINARY CLINICS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
16.5.1 NORTH AMERICA
16.5.2 EUROPE
16.5.3 ASIA-PACIFIC
16.5.4 SOUTH AMERICA
16.5.5 MIDDLE EAST & AFRICA
16.6 MIDDLE EAST AND AFRICA ANIMAL FARMS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
16.6.1 NORTH AMERICA
16.6.2 EUROPE
16.6.3 ASIA-PACIFIC
16.6.4 SOUTH AMERICA
16.6.5 MIDDLE EAST & AFRICA
16.7 MIDDLE EAST AND AFRICA HOME CARE IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
16.7.1 NORTH AMERICA
16.7.2 EUROPE
16.7.3 ASIA-PACIFIC
16.7.4 SOUTH AMERICA
16.7.5 MIDDLE EAST & AFRICA
16.8 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
16.8.1 PRIVATE
16.8.2 PUBLIC
16.9 MIDDLE EAST AND AFRICA VETERINARY HOSPITALS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
16.9.1 NORTH AMERICA
16.9.2 EUROPE
16.9.3 ASIA-PACIFIC
16.9.4 SOUTH AMERICA
16.9.5 MIDDLE EAST & AFRICA
16.1 MIDDLE EAST AND AFRICA PET SHOPS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
16.10.1 NORTH AMERICA
16.10.2 EUROPE
16.10.3 ASIA-PACIFIC
16.10.4 SOUTH AMERICA
16.10.5 MIDDLE EAST & AFRICA
16.11 MIDDLE EAST AND AFRICA OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
16.11.1 NORTH AMERICA
16.11.2 EUROPE
16.11.3 ASIA-PACIFIC
16.11.4 SOUTH AMERICA
16.11.5 MIDDLE EAST & AFRICA
17 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL
17.1 OVERVIEW
17.2 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
17.2.1 RETAIL SALES
17.2.2 DIRECT TENDER
17.2.3 OTHER
17.3 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
17.3.1 RETAIL SALES
17.3.2 DIRECT TENDER
17.3.3 OTHER
17.4 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNIT)
17.4.1 RETAIL SALES
17.4.2 DIRECT TENDER
17.4.3 OTHER
17.5 MIDDLE EAST AND AFRICA RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
17.5.1 OFFLINE SALES
17.5.2 ONLINE SALES
17.6 MIDDLE EAST AND AFRICA RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
17.6.1 NORTH AMERICA
17.6.2 EUROPE
17.6.3 ASIA-PACIFIC
17.6.4 SOUTH AMERICA
17.6.5 MIDDLE EAST & AFRICA
17.7 MIDDLE EAST AND AFRICA DIRECT TENDER IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
17.7.1 NORTH AMERICA
17.7.2 EUROPE
17.7.3 ASIA-PACIFIC
17.7.4 SOUTH AMERICA
17.7.5 MIDDLE EAST & AFRICA
17.8 MIDDLE EAST AND AFRICA OTHER IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
17.8.1 NORTH AMERICA
17.8.2 EUROPE
17.8.3 ASIA-PACIFIC
17.8.4 SOUTH AMERICA
17.8.5 MIDDLE EAST & AFRICA
18 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY REGION
18.1 MIDDLE EAST AND AFRICA
18.1.1 SOUTH AFRICA
18.1.2 SAUDI ARABIA
18.1.3 EGYPT
18.1.4 UNITED ARAB EMIRATES
18.1.5 ISRAEL
18.1.6 QATAR
18.1.7 KUWAIT
18.1.8 OMAN
18.1.9 BAHRAIN
18.1.10 REST OF MIDDLE EAST & AFRICA
19 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET COMPANY LANDSCAPE
19.1 COMPANY SHARE ANALYSIS: GLOBAL
20 SWOT ANALYSIS
21 COMPANY PROFILES
21.1 ZOETIS SERVICES LLC
21.1.1 COMPANY SNAPSHOT
21.1.2 REVENUE ANALYSIS
21.1.3 COMPANY SHARE ANALYSIS
21.1.4 PRODUCT PORTFOLIO
21.1.5 RECENT DEVELOPMENT
21.2 MERCK & CO., INC
21.2.1 COMPANY SNAPSHOT
21.2.2 REVENUE ANALYSIS
21.2.3 COMPANY SHARE ANALYSIS
21.2.4 PRODUCT PORTFOLIO
21.2.5 RECENT DEVELOPMENT
21.3 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
21.3.1 COMPANY SNAPSHOT
21.3.2 COMPANY SHARE ANALYSIS
21.3.3 PRODUCT PORTFOLIO
21.3.4 RECENT DEVELOPMENT
21.4 ELANCO
21.4.1 COMPANY SNAPSHOT
21.4.2 REVENUE ANALYSIS
21.4.3 COMPANY SHARE ANALYSIS
21.4.4 PRODUCT PORTFOLIO
21.4.5 RECENT DEVELOPMENT
21.5 CEVA
21.5.1 COMPANY SNAPSHOT
21.5.2 COMPANY SHARE ANALYSIS
21.5.3 PRODUCT PORTFOLIO
21.5.4 RECENT DEVELOPMENT
21.6 AGROVET MARKET ANIMAL HEALTH
21.6.1 COMPANY SNAPSHOT
21.6.2 PRODUCT PORTFOLIO
21.6.3 RECENT DEVELOPMENT
21.7 BIMEDA, INC.
21.7.1 COMPANY SNAPSHOT
21.7.2 PRODUCT PORTFOLIO
21.7.3 RECENT DEVELOPMENT
21.8 BIOGÉNESIS BAGÓ
21.8.1 COMPANY SNAPSHOT
21.8.2 PRODUCT PORTFOLIO
21.8.3 RECENT DEVELOPMENT
21.9 BIOVETA, A.S
21.9.1 COMPANY SNAPSHOT
21.9.2 PRODUCT PORTFOLIO
21.9.3 RECENT DEVELOPMENT
21.1 CHANELLE PHARMA
21.10.1 COMPANY SNAPSHOT
21.10.2 PRODUCT PORTFOLIO
21.10.3 RECENT DEVELOPMENT/NEWS
21.11 DECHRA PHARMACEUTICALS
21.11.1 COMPANY SNAPSHOT
21.11.2 PRODUCT PORTFOLIO
21.11.3 RECENT DEVELOPMENT
21.12 FARMABASE
21.12.1 COMPANY SNAPSHOT
21.12.2 PRODUCT PORTFOLIO
21.12.3 RECENT DEVELOPMENT
21.13 HUVEPHARMA
21.13.1 COMPANY SNAPSHOT
21.13.2 PRODUCT PORTFOLIO
21.13.3 RECENT DEVELOPMENT
21.14 INMED ANIMAL HEALTH
21.14.1 COMPANY SNAPSHOT
21.14.2 PRODUCT PORTFOLIO
21.14.3 RECENT DEVELOPMENT/NEWS
21.15 KRKA, D. D., NOVO MESTO
21.15.1 COMPANY SNAPSHOT
21.15.2 REVENUE ANALYSIS
21.15.3 PRODUCT PORTFOLIO
21.15.4 RECENT DEVELOPMENT
21.16 KYORITSU SEIYAKU CORPORATION
21.16.1 COMPANY SNAPSHOT
21.16.2 PRODUCT PORTFOLIO
21.16.3 RECENT DEVELOPMENT
21.17 NORBROOK
21.17.1 COMPANY SNAPSHOT
21.17.2 PRODUCT PORTFOLIO
21.17.3 RECENT DEVELOPMENT
21.18 OUROFINO SAÚDE ANIMAL
21.18.1 COMPANY SNAPSHOT
21.18.2 REVENUE ANALYSIS
21.18.3 PRODUCT PORTFOLIO
21.18.4 RECENT DEVELOPMENT
21.19 ATCO HEALTHCARE PVT. LTD.
21.19.1 COMPANY SNAPSHOT
21.19.2 PRODUCT PORTFOLIO
21.19.3 RECENT DEVELOPMENT
21.2 PECUS HEALTHCARE PVT LTD
21.20.1 COMPANY SNAPSHOT
21.20.2 PRODUCT PORTFOLIO
21.20.3 RECENT DEVELOPMENT
21.21 PETIQ, LLC
21.21.1 COMPANY SNAPSHOT
21.21.2 PRODUCT PORTFOLIO
21.21.3 RECENT DEVELOPMENT
21.22 PHIBRO
21.22.1 COMPANY SNAPSHOT
21.22.2 PRODUCT PORTFOLIO
21.22.3 RECENT DEVELOPMENT/NEWS
21.23 PRODIVET PHARMACEUTICALS
21.23.1 COMPANY SNAPSHOT
21.23.2 PRODUCT PORTFOLIO
21.23.3 RECENT DEVELOPMENT
21.24 VETOQUINOL
21.24.1 COMPANY SNAPSHOT
21.24.2 REVENUE ANALYSIS
21.24.3 PRODUCT PORTFOLIO
21.24.4 RECENT DEVELOPMENT
21.25 VIRBAC.
21.25.1 COMPANY SNAPSHOT
21.25.2 REVENUE ANALYSIS
21.25.3 PRODUCT PORTFOLIO
21.25.4 RECENT DEVELOPMENT
21.26 VIYASH SCIENTIFIC LTD.
21.26.1 COMPANY SNAPSHOT
21.26.2 PRODUCT PORTFOLIO
21.26.3 RECENT DEVELOPMENT/NEWS
21.26.4 PRODUCT PORTFOLIO
21.26.5 RECENT DEVELOPMENT
22 QUESTIONNAIRE
23 RELATED REPORTS
List of Table
TABLE 1 PESTEL ANALYSIS OVERVIEW
TABLE 2 GROWTH OPPORTUNITY MAPPING
TABLE 3 CLINICAL TRIAL MARKET FOR MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET
TABLE 4 DISTRIBUTION OF PROJECTS BY PARASITE TYPE AND PHASE MIDDLE EAST AND AFRICA ANIMAL
TABLE 5 DISTRIBUTION OF PROJECTS BY SCIENTIFIC APPROACH AND PHASE MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET
TABLE 6 COMPARATIVE EVOLUTION OF R&D STRATEGIES
TABLE 7 ANIMAL PARASITICIDE PRODUCT DEVELOPMENT LIFECYCLE
TABLE 8 REGULATORY MILESTONES ACROSS THE PRODUCT DEVELOPMENT LIFECYCLE
TABLE 9 EMERGING THERAPEUTIC INNOVATION ASSESSMENT
TABLE 10 MAJOR COLLABORATION MODELS IN ANIMAL PARASITICIDE R&D
TABLE 11 TEN-YEAR MARKET FORECAST, 2023–2033 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 13 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 14 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNIT)
TABLE 15 MIDDLE EAST AND AFRICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 16 MIDDLE EAST AND AFRICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 17 MIDDLE EAST AND AFRICA ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 18 MIDDLE EAST AND AFRICA CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 19 MIDDLE EAST AND AFRICA ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 20 MIDDLE EAST AND AFRICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 21 MIDDLE EAST AND AFRICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 22 MIDDLE EAST AND AFRICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 23 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 24 MIDDLE EAST AND AFRICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 25 MIDDLE EAST AND AFRICA BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 26 MIDDLE EAST AND AFRICA IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 27 MIDDLE EAST AND AFRICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 28 MIDDLE EAST AND AFRICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 29 MIDDLE EAST AND AFRICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 30 MIDDLE EAST AND AFRICA ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 31 MIDDLE EAST AND AFRICA ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 32 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 33 MIDDLE EAST AND AFRICA ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 34 MIDDLE EAST AND AFRICA ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 35 MIDDLE EAST AND AFRICA CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 36 MIDDLE EAST AND AFRICA BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 37 MIDDLE EAST AND AFRICA IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 38 MIDDLE EAST AND AFRICA OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 39 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 40 MIDDLE EAST AND AFRICA PRESCRIPTION IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 41 MIDDLE EAST AND AFRICA OVER THE COUNTER (OTC) IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 42 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 43 MIDDLE EAST AND AFRICA BRANDED IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 44 MIDDLE EAST AND AFRICA GENERIC IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 45 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 46 MIDDLE EAST AND AFRICA TOPICAL IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 47 MIDDLE EAST AND AFRICA ORAL IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 48 MIDDLE EAST AND AFRICA INJECTABLES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 49 MIDDLE EAST AND AFRICA OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 50 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 51 MIDDLE EAST AND AFRICA SOLUTION IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 52 MIDDLE EAST AND AFRICA TABLETS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 53 MIDDLE EAST AND AFRICA SPRAYS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 54 MIDDLE EAST AND AFRICA OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 55 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 56 MIDDLE EAST AND AFRICA FLEAS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 57 MIDDLE EAST AND AFRICA TICKS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 58 MIDDLE EAST AND AFRICA ROUND WORMS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 59 MIDDLE EAST AND AFRICA HOOKWORMS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 60 MIDDLE EAST AND AFRICA EAR MITES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 61 MIDDLE EAST AND AFRICA OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 62 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 63 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 64 MIDDLE EAST AND AFRICA COMPANION ANIMAL IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 65 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 66 MIDDLE EAST AND AFRICA FARM ANIMALS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 67 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 68 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 69 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNIT)
TABLE 70 MIDDLE EAST AND AFRICA VETERINARY CLINICS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 71 MIDDLE EAST AND AFRICA ANIMAL FARMS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 72 MIDDLE EAST AND AFRICA HOME CARE IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 73 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 74 MIDDLE EAST AND AFRICA VETERINARY HOSPITALS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 75 MIDDLE EAST AND AFRICA PET SHOPS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 76 MIDDLE EAST AND AFRICA OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 77 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 78 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 79 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNIT)
TABLE 80 MIDDLE EAST AND AFRICA RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 81 MIDDLE EAST AND AFRICA RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 82 MIDDLE EAST AND AFRICA DIRECT TENDER IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 83 MIDDLE EAST AND AFRICA OTHER IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 84 MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 85 MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
TABLE 86 USD THOUSAND
TABLE 87 MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 88 MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 89 MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNIT)
TABLE 90 MIDDLE EAST & AFRICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 91 MIDDLE EAST & AFRICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 92 MIDDLE EAST & AFRICA ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 93 MIDDLE EAST & AFRICA CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 94 MIDDLE EAST & AFRICA ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 95 MIDDLE EAST & AFRICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 96 MIDDLE EAST & AFRICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 97 MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 98 MIDDLE EAST & AFRICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 99 MIDDLE EAST & AFRICA BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 100 MIDDLE EAST & AFRICA IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 101 MIDDLE EAST & AFRICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 102 MIDDLE EAST & AFRICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 103 MIDDLE EAST & AFRICA ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 104 MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 105 MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 106 MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 107 MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 108 MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 109 MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 110 MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 111 MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 112 MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 113 MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 114 MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 115 MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNIT)
TABLE 116 MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 117 MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 118 MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 119 MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNIT)
TABLE 120 MIDDLE EAST & AFRICA RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 121 USD THOUSAND
TABLE 122 SOUTH AFRICA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 123 SOUTH AFRICA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 124 SOUTH AFRICA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNIT)
TABLE 125 SOUTH AFRICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 126 SOUTH AFRICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 127 SOUTH AFRICA ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 128 SOUTH AFRICA CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 129 SOUTH AFRICA ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 130 SOUTH AFRICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 131 SOUTH AFRICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 132 SOUTH AFRICA ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 133 SOUTH AFRICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 134 SOUTH AFRICA BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 135 SOUTH AFRICA IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 136 SOUTH AFRICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 137 SOUTH AFRICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 138 SOUTH AFRICA ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 139 SOUTH AFRICA ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 140 SOUTH AFRICA ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 141 SOUTH AFRICA ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 142 SOUTH AFRICA ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 143 SOUTH AFRICA ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 144 SOUTH AFRICA ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 145 SOUTH AFRICA ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 146 SOUTH AFRICA ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 147 SOUTH AFRICA ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 148 SOUTH AFRICA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 149 SOUTH AFRICA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 150 SOUTH AFRICA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNIT)
TABLE 151 SOUTH AFRICA ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 152 SOUTH AFRICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 153 SOUTH AFRICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 154 SOUTH AFRICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNIT)
TABLE 155 SOUTH AFRICA RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 156 USD THOUSAND
TABLE 157 SAUDI ARABIA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 158 SAUDI ARABIA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 159 SAUDI ARABIA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNITS)
TABLE 160 SAUDI ARABIA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 161 SAUDI ARABIA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 162 SAUDI ARABIA ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 163 SAUDI ARABIA CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 164 SAUDI ARABIA ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 165 SAUDI ARABIA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 166 SAUDI ARABIA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 167 SAUDI ARABIA ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 168 SAUDI ARABIA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 169 SAUDI ARABIA BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 170 SAUDI ARABIA IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 171 SAUDI ARABIA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 172 SAUDI ARABIA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 173 SAUDI ARABIA ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 174 SAUDI ARABIA ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 175 SAUDI ARABIA ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 176 SAUDI ARABIA ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 177 SAUDI ARABIA ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 178 SAUDI ARABIA ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 179 SAUDI ARABIA ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 180 SAUDI ARABIA ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 181 SAUDI ARABIA ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 182 SAUDI ARABIA ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 183 SAUDI ARABIA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 184 SAUDI ARABIA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 185 SAUDI ARABIA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNITS)
TABLE 186 SAUDI ARABIA ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 187 SAUDI ARABIA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 188 SAUDI ARABIA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 189 SAUDI ARABIA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNITS)
TABLE 190 SAUDI ARABIA RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 191 USD THOUSNAD
TABLE 192 EGYPT ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 193 EGYPT ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 194 EGYPT ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNITS)
TABLE 195 EGYPT ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 196 EGYPT ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 197 EGYPT ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 198 EGYPT CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 199 EGYPT ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 200 EGYPT ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 201 EGYPT ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 202 EGYPT ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 203 EGYPT ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 204 EGYPT BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 205 EGYPT IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 206 EGYPT ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 207 EGYPT ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 208 EGYPT ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 209 EGYPT ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 210 EGYPT ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 211 EGYPT ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 212 EGYPT ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 213 EGYPT ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 214 EGYPT ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 215 EGYPT ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 216 EGYPT ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 217 EGYPT ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 218 EGYPT ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 219 EGYPT ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 220 EGYPT ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNITS)
TABLE 221 EGYPT ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 222 EGYPT ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 223 EGYPT ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 224 EGYPT ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNITS)
TABLE 225 EGYPT RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 226 USD THOUSNAD
TABLE 227 UNITED ARAB EMIRATES ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 228 UNITED ARAB EMIRATES ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 229 UNITED ARAB EMIRATES ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNITS)
TABLE 230 UNITED ARAB EMIRATES ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 231 UNITED ARAB EMIRATES ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 232 UNITED ARAB EMIRATES ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 233 UNITED ARAB EMIRATES CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 234 UNITED ARAB EMIRATES ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 235 UNITED ARAB EMIRATES ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 236 UNITED ARAB EMIRATES ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 237 UNITED ARAB EMIRATES ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 238 UNITED ARAB EMIRATES ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 239 UNITED ARAB EMIRATES BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 240 UNITED ARAB EMIRATES IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 241 UNITED ARAB EMIRATES ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 242 UNITED ARAB EMIRATES ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 243 UNITED ARAB EMIRATES ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 244 UNITED ARAB EMIRATES ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 245 UNITED ARAB EMIRATES ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 246 UNITED ARAB EMIRATES ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 247 UNITED ARAB EMIRATES ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 248 UNITED ARAB EMIRATES ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 249 UNITED ARAB EMIRATES ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 250 UNITED ARAB EMIRATES ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 251 UNITED ARAB EMIRATES ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 252 UNITED ARAB EMIRATES ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 253 UNITED ARAB EMIRATES ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 254 UNITED ARAB EMIRATES ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 255 UNITED ARAB EMIRATES ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNITS)
TABLE 256 UNITED ARAB EMIRATES ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 257 UNITED ARAB EMIRATES ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 258 UNITED ARAB EMIRATES ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 259 UNITED ARAB EMIRATES ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNITS)
TABLE 260 UNITED ARAB EMIRATESRETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 261 USD THOUSNAD
TABLE 262 ISRAEL ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 263 ISRAEL ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 264 ISRAEL ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNITS)
TABLE 265 ISRAEL ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 266 ISRAEL ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 267 ISRAEL ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 268 ISRAEL CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 269 ISRAEL ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 270 ISRAEL ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 271 ISRAEL ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 272 ISRAEL ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 273 ISRAEL ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 274 ISRAEL BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 275 ISRAEL IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 276 ISRAEL ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 277 ISRAEL ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 278 ISRAEL ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 279 ISRAEL ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 280 ISRAEL ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 281 ISRAEL ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 282 ISRAEL ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 283 ISRAEL ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 284 ISRAEL ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 285 ISRAEL ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 286 ISRAEL ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 287 ISRAEL ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 288 ISRAEL ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 289 ISRAEL ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 290 ISRAEL ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNITS)
TABLE 291 ISRAEL ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 292 ISRAEL ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 293 ISRAEL ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 294 ISRAEL ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNITS)
TABLE 295 ISRAEL RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 296 USD THOUSNAD
TABLE 297 QATAR ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 298 QATAR ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 299 QATAR ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNITS)
TABLE 300 QATAR ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 301 QATAR ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 302 QATAR ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 303 QATAR CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 304 QATAR ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 305 QATAR ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 306 QATAR ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 307 QATAR ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 308 QATAR ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 309 QATAR BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 310 QATAR IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 311 QATAR ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 312 QATAR ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 313 QATAR ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 314 QATAR ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 315 QATAR ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 316 QATAR ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 317 QATAR ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 318 QATAR ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 319 QATAR ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 320 QATAR ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 321 QATAR ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 322 QATAR ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 323 QATAR ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 324 QATAR ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 325 QATAR ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNITS)
TABLE 326 QATAR ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 327 QATAR ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 328 QATAR ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 329 QATAR ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNITS)
TABLE 330 QATAR RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 331 USD THOUSNAD
TABLE 332 KUWAIT ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 333 KUWAIT ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 334 KUWAIT ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNITS)
TABLE 335 KUWAIT ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 336 KUWAIT ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 337 KUWAIT ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 338 KUWAIT CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 339 KUWAIT ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 340 KUWAIT ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 341 KUWAIT ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 342 KUWAIT ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 343 KUWAIT ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 344 KUWAIT BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 345 KUWAIT IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 346 KUWAIT ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 347 KUWAIT ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 348 KUWAIT ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 349 KUWAIT ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 350 KUWAIT ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 351 KUWAIT ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 352 KUWAIT ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 353 KUWAIT ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 354 KUWAIT ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 355 KUWAIT ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 356 KUWAIT ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 357 KUWAIT ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 358 KUWAIT ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 359 KUWAIT ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 360 KUWAIT ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNITS)
TABLE 361 KUWAIT ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 362 KUWAIT ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 363 KUWAIT ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 364 KUWAIT ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNITS)
TABLE 365 KUWAIT RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 366 USD THOUSNAD
TABLE 367 OMAN ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 368 OMAN ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 369 OMAN ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNITS)
TABLE 370 OMAN ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 371 OMAN ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 372 OMAN ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 373 OMAN CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 374 OMAN ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 375 OMAN ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 376 OMAN ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 377 OMAN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 378 OMAN ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 379 OMAN BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 380 OMAN IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 381 OMAN ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 382 OMAN ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 383 OMAN ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 384 OMAN ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 385 OMAN ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 386 OMAN ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 387 OMAN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 388 OMAN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 389 OMAN ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 390 OMAN ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 391 OMAN ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 392 OMAN ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 393 OMAN ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 394 OMAN ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 395 OMAN ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNITS)
TABLE 396 OMAN ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 397 OMAN ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 398 OMAN ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 399 OMAN ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNITS)
TABLE 400 OMAN RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 401 USD THOUSNAD
TABLE 402 BAHRAIN ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 403 BAHRAIN ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 404 BAHRAIN ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNITS)
TABLE 405 BAHRAIN ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 406 BAHRAIN ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 407 BAHRAIN ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 408 BAHRAIN CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 409 BAHRAIN ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 410 BAHRAIN ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 411 BAHRAIN ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 412 BAHRAIN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 413 BAHRAIN ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 414 BAHRAIN BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 415 BAHRAIN IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 416 BAHRAIN ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 417 BAHRAIN ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 418 BAHRAIN ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 419 BAHRAIN ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 420 BAHRAIN ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 421 BAHRAIN ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 422 BAHRAIN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 423 BAHRAIN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 424 BAHRAIN ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 425 BAHRAIN ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 426 BAHRAIN ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 427 BAHRAIN ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 428 BAHRAIN ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 429 BAHRAIN ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 430 BAHRAIN ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNITS)
TABLE 431 BAHRAIN ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 432 BAHRAIN ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 433 BAHRAIN ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 434 BAHRAIN ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNITS)
TABLE 435 BAHRAIN RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 436 USD THOUSNAD
TABLE 437 REST OF MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 438 REST OF MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 439 REST OF MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNITS)
TABLE 440 REST OF MIDDLE EAST & AFRICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 441 REST OF MIDDLE EAST & AFRICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 442 REST OF MIDDLE EAST & AFRICA ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 443 REST OF MIDDLE EAST & AFRICA CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 444 REST OF MIDDLE EAST & AFRICA ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 445 REST OF MIDDLE EAST & AFRICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 446 REST OF MIDDLE EAST & AFRICA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 447 REST OF MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 448 REST OF MIDDLE EAST & AFRICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 449 REST OF MIDDLE EAST & AFRICA BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 450 REST OF MIDDLE EAST & AFRICA IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 451 REST OF MIDDLE EAST & AFRICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 452 REST OF MIDDLE EAST & AFRICA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 453 REST OF MIDDLE EAST & AFRICA ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 454 REST OF MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 455 REST OF MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 456 REST OF MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 457 REST OF MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 458 REST OF MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 459 REST OF MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 460 REST OF MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 461 REST OF MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 462 REST OF MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 463 REST OF MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 464 REST OF MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 465 REST OF MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNITS)
TABLE 466 REST OF MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 467 REST OF MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 468 REST OF MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 469 REST OF MIDDLE EAST & AFRICA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNITS)
TABLE 470 REST OF MIDDLE EAST & AFRICA RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
List of Figure
FIGURE 1 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: MULTIVARIVATE MODELING
FIGURE 10 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: PRODUCT TYPE TIMELINE CURVE
FIGURE 11 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: APPLICATION COVERAGE GRID
FIGURE 12 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: SEGMENTATION
FIGURE 13 THREE SEGMENTS COMPRISE THE MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET, BY PRODUCT (2025)
FIGURE 14 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: EXECUTIVE SUMMARY
FIGURE 15 INCREASING BURDEN OF VECTOR-BORNE PARASITES AFFECTING ANIMAL HEALTH IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET DURING THE FORECAST PERIOD OF 2026 TO 2033.
FIGURE 16 ECTOPARASITICIDES IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET IN 2026 & 2033
FIGURE 17 STRATEGIC DECISIONS
FIGURE 18 PORTER’S FIVE FORCES ANALYSIS
FIGURE 19 PESTEL ANALYSIS
FIGURE 20 TOP ENTITIES BASED ON R&D GLANCE FOR MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET
FIGURE 21 R & D ANALYSIS
FIGURE 22 DROC ANALYSIS
FIGURE 23 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET : BY PRODUCT, 2025
FIGURE 24 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET : BY PRODUCT, 2026 TO 2033 (USD THOUSAND)
FIGURE 25 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET : BY PRODUCT, CAGR (2026- 2033)
FIGURE 26 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET : BY PRODUCT, LIFELINE CURVE
FIGURE 27 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: BY DRUG CLASS, 2025
FIGURE 28 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: BY DRUG CLASS, 2026 TO 2033 (USD THOUSAND)
FIGURE 29 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: BY DRUG CLASS, CAGR (2026- 2033)
FIGURE 30 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: BY P DRUG CLASS, LIFELINE CURVE
FIGURE 31 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET : BY MODE OF PURCHASE , 2025
FIGURE 32 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET : BY MODE OF PURCHASE , 2026 TO 2033 (USD THOUSAND)
FIGURE 33 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET : BY MODE OF PURCHASE , CAGR (2026- 2033)
FIGURE 34 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET : BY MODE OF PURCHASE , LIFELINE CURVE
FIGURE 35 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: BY DRUG TYPE, 2025
FIGURE 36 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: BY DRUG TYPE, TO 2033 (USD THOUSAND)
FIGURE 37 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: BY DRUG TYPE, CAGR (2026- 2033)
FIGURE 38 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: BY DRUG TYPE, LIFELINE CURVE
FIGURE 39 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET : BY ROUTE OF ADMINISTRATION, 2025
FIGURE 40 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET : BY ROUTE OF ADMINISTRATION, 2026 TO 2033 (USD THOUSAND)
FIGURE 41 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET : BY ROUTE OF ADMINISTRATION, CAGR (2026- 2033)
FIGURE 42 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET : BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 43 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET : BY DOSAGE FORM, 2025
FIGURE 44 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET : BY DOSAGE FORM, 2026 TO 2033 (USD THOUSAND)
FIGURE 45 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET : BY DOSAGE FORM, CAGR (2026- 2033)
FIGURE 46 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET : BY DOSAGE FORM, LIFELINE CURVE
FIGURE 47 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: BY DISEASE TYPE, 2025
FIGURE 48 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: BY DISEASE TYPE, 2026 TO 2033 (USD THOUSAND)
FIGURE 49 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: BY DISEASE TYPE, CAGR (2026- 2033)
FIGURE 50 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: BY DISEASE TYPE, LIFELINE CURVE
FIGURE 51 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: BY ANIMAL TYPE, 2025
FIGURE 52 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: BY ANIMAL TYPE, 2026 TO 2033 (USD THOUSAND)
FIGURE 53 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: BY ANIMAL TYPE, CAGR (2026- 2033)
FIGURE 54 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 55 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: BY END USER, 2025
FIGURE 56 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: BY END USER, 2026 TO 2033 (USD THOUSAND)
FIGURE 57 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: BY END USER, CAGR (2026- 2033)
FIGURE 58 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: BY END USER, LIFELINE CURVE
FIGURE 59 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: BY DISTRIBUTION CHANNEL, 2025
FIGURE 60 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: BY DISTRIBUTION CHANNEL, 2026 TO 2033 (USD THOUSAND)
FIGURE 61 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2026- 2033)
FIGURE 62 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 63 MIDDLE EAST AND AFRICA FMD VACCINES MARKET: SNAPSHOT (2025)
FIGURE 64 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET: COMPANY SHARE 2025 (%)
FIGURE 65 MIDDLE EAST AND AFRICA ANIMAL PARASITICIDES MARKET-, SNAPSHOT (2025)
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
